Affordable Access

Publisher Website

Therapeutic effects of bone marrow-derived mesenchymal stem cells on pulmonary impact injury complicated with endotoxemia in rats

Authors
Journal
International Immunopharmacology
1567-5769
Publisher
Elsevier
Volume
15
Issue
2
Identifiers
DOI: 10.1016/j.intimp.2012.12.008
Keywords
  • Acute Lung Injury
  • Mesenchymal Stem Cells
  • Transplantation
  • Endotoxemia
  • Inflammation
Disciplines
  • Biology
  • Medicine
  • Pharmacology

Abstract

Abstract Previous studies have demonstrated that acute lung injury (ALI) is associated with significant mortality and so far no effective pharmacotherapy is shown to reverse the natural progression. This study aims to investigate whether the transplantation of bone marrow derived mesenchymal stem cells (MSCs) might restore damaged pulmonary function and tissue structure in ALI. By using a sublethal chest impact injury plus endotoxemia model, MSCs were intravenously transplanted into the injured rats 2h after trauma. The blood samples were obtained for determination of blood gas. Bronchoalveolar lavage fluid (BALF) was collected for analysis of inflammatory cell count and cytokine (TNF-α, IL-1β, IL-6 and IL-10) levels. The left lower lobes of the lungs, nearby the impact zone, were collected for SRY gene analysis and histological examination and scoring. After engraftment of MSCs, the number of inflammatory cells in BALF was decreased. Meanwhile, the secretions of pro-inflammatory TNF-α and IL-6 were alleviated, while the secretion of anti-inflammatory IL-10 was elevated. Engraftment of MSCs improved the pulmonary gas exchanges, alleviated the lung injury, and reduced the rats' mortality. These results suggested that the MSCs based measures might be a promising strategy in trauma and endotoxemia induced ALI treatment.

There are no comments yet on this publication. Be the first to share your thoughts.